China Resources Pharmaceutical Group Limited
HKSE: 3320.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Xiaosong Bai
- Employees
- 72,700
- Headquarters
- Wan Chai, Hong Kong SAR China
- IPO year
- 2016
- Market cap
- HK$32.4B
- Website
- https://www.crpharm.com
Loading 3320…
Loading profile data…Frequently asked questions about 3320
What does China Resources Pharmaceutical Group Limited (3320.HK) do?
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and Hong Kong. The company operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmac...
Where does 3320.HK trade?
China Resources Pharmaceutical Group Limited (3320.HK) trades on the Hong Kong Stock Exchange.
What sector is 3320.HK in?
China Resources Pharmaceutical Group Limited (3320.HK) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of China Resources Pharmaceutical Group Limited?
Xiaosong Bai is the chief executive officer of China Resources Pharmaceutical Group Limited (3320.HK).
Where is China Resources Pharmaceutical Group Limited headquartered?
China Resources Pharmaceutical Group Limited is headquartered in Hong Kong SAR China.
Does 3320.HK pay a dividend?
Yes — China Resources Pharmaceutical Group Limited (3320.HK) paid a trailing twelve-month dividend of HKD 0.13 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 3320.HK go public?
China Resources Pharmaceutical Group Limited (3320.HK) completed its initial public offering in 2016.